Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas

Neurosurgery

Volumn 57, Issue 1 SUPPL., 2005, Pages

  Gay, Emmanuel ^a   Vuillez, Jean Philippe ^a   Palombi, Olivier ^a   Brard, Pierre Yves ^a   Bessou, Pierre ^a   Passagia, Jean Guy ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Bone invasion; Intraoperative radiodetection; Meningiomas; Somatostatin receptor scintigraphy

Indexed keywords

PENTETATE INDIUM IN 111; PENTETREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GAMMA SCINTIGRAPHY; HUMAN; INTERMETHOD COMPARISON; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DETECTION; SPHENOID; TUMOR LOCALIZATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; OCTREOTIDE; POSTOPERATIVE CARE; PROGNOSIS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SKULL NEOPLASMS; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 21744440526     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000163490.15578.FF     Document Type: Article

References (26)

1. Adams S, Baum RP, Hertel A, Wenisch HJ, Staib-Sebler E, Herrmann G, Encke A, Hor G: Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 39:1155-1160, 1998.
2. Black PMcL: Meningiomas. Neurosurgery 32:643-657, 1993.
3. Black PMcL: Hormones, radiosurgery and virtual reality: New aspects of meningioma management. Can J Neurol Sci 24:302-306, 1997.
4. Bohuslavizki KH, Brenner W, Braunsdorf WE, Behnke A, Tinnemeyer S, Hugo HH, Jahn N, Wolf H, Sippel C, Clausen M, Mehdorn HM, Henze E: Somatostatin receptor scintigraphy in the differential diagnosis of meningioma. Nucl Med Commun 17:302-310, 1996.
5. De Menis E, Tulipano G, Villa S, Billeci D, Bonfanti C, Pollara P, Pauletto P, Giustina A: Development of a meningioma in a patient with acromegaly during octreotide treatment: Are there any causal relationships? J Endocrinol Invest 26:359-363, 2003.
6. Epelbaum J, Agid F, Agid Y, Beaudet A, Bertrand P, Enjalbert A, Heidet V, Kordon C, Krantic S, Leonard JF: Somatostatin receptors in brain and pituitary. Horm Res 31:45-50, 1989.
7. Garcia-Luna PP, Relimpio F, Pumar A, Pereira JL, Leal-Cerro A, Trujillo F, Cortes A, Astorga R: Clinical use of octreotide in unresectable meningiomas: A report of three cases. J Neurosurg Sci 37:237-241, 1993.
8. Hellwig D, Samnick S, Reif J, Romeike BF, Reith W, Moringlane JR, Kirsch CM: Comparison of Tc-99m depreotide and In-111 octreotide in recurrent meningioma. Clin Nucl Med 27:781-784, 2002.
9. 111indium (DTPA-octreotide)-scintigraphy in meningioma patients. Acta Neurochir (Wien) 126:63-71, 1994.
10. 68Ga-DOTATOC: Preliminary data. Eur J Nucl Med 28:1751-1757, 2001.
11. Kallio M, Sankila R, Hakulinen T, Jääskeläinen J: Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2-12, 1992.
12. Klutmann S, Bohuslavizki KH, Brenner W, Behnke A, Tietje N, Kroger S, Hugo HH, Mehdorn HM, Clausen M, Henze E: Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma. J Nucl Med 39:1913-1917, 1998.
13. Koper JW, Markstein R, Kohler C, Kwekkeboom DJ, Avezaat CJ, Lamberts SW, Reubi JC: Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 74:543-547, 1992.
14. Kunert-Radek J, Stepien H, Radek A, Pawlikowski M: Somatostatin suppression of meningioma cell proliferation in vitro. Acta Neurol Scand 75:434-436, 1987.
15. Lamberts SW, Reubi JC, Krenning EP: Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors. J Steroid Biochem Mol Biol 43:185-188, 1992.
16. 111In-octreotide. Nucl Med Commun 16:756-766, 1995.
17. Meewes C, Bohuslavizki KH, Krisch B, Held-Feindt J, Henze E, Clausen M: Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas. J Nucl Med 42:1338-1345, 2001.
18. Ohrvall U, Westlin JE, Nilsson S, Juhlin C, Rastad J, Lundqvist H, Akerstrom G: Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer 80:2490-2494, 1997.
19. Perkins A: Perioperative nuclear medicine. Eur J Nucl Med 20:573-575, 1993.
20. Pitre S, Menard L, Ricard M, Solal M, Garbay J, Charon Y: A hand-held imaging probe for radio-guided surgery: Physics performance and preliminary clinical experience. Eur J Nucl Med Mol Imaging 30:339-343, 2003.
21. 32P tumour marker. Acta Neurochir (Wien) 97:89-94, 1989.
22. Reubi JC, Chayvialle JA, Franc B, Cohen R, Calmettes C, Modigliani E: Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 64:567-573, 1991.
23. Reubi JC, Maurer R, Klijn JG, Stefanko SZ, Foekens JA, Blaauw G, Blankenstein MA, Lamberts SW: High incidence of somatostatin receptors in human meningiomas: Biochemical characterization. J Clin Endocrinol Metab 63:433-438, 1986.
24. Reubi JC, Maurer R, von Werder K, Torhorst J, Klijn JG, Lamberts SW: Somatostatin receptors in human endocrine tumors. Cancer Res 47:551-558, 1987.
25. Reubi JC, Schaer JC, Waser B, Mengod G: Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human rumors using in situ hybridization. Cancer Res 54:3455-3459, 1994.
26. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V: Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865-1874, 2000.